What type of testing is mandatory for all donated plasma?

In the context of plasma donation, infectious disease testing is mandatory for all donated plasma. This testing is critical in ensuring the safety of the plasma collected for therapeutic use. The testing typically screens for various infectious diseases such as HIV, Hepatitis B and C, syphilis, and other pathogens that could potentially be transmitted through blood products. This process protects both the recipients who receive the plasma-derived therapies and the overall integrity of the blood supply.

While health history assessments and blood type identification are important components of the donation process and contribute to donor safety and recipient compatibility, they do not specifically address the concerns of infectious diseases. Genetic testing, on the other hand, is not a standard requirement for all plasma donations, as the focus is primarily on ensuring the absence of infectious agents. Consequently, the mandatory nature of infectious disease testing is a cornerstone of plasma donation protocols, prioritizing public health and safety.